EUCTR2021-002898-26-FRActive, not recruitingPhase 1
Contribution of PET/CT with Gallium 68 citrate (68Ga-PET/CT) for the diagnosis of prosthetic valve infective endocarditis - CiGal-EI-TEP
CHU DE BORDEAUX0 sites40 target enrollmentStarted: April 27, 2022Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •- Adult patient (over 18 years old);
- •- Patient with a prosthetic heart valve;
- •- Patient suspected of infective endocarditis (on clinical and/or microbiological and/or imaging data);
- •- Patient whose history is discussed in the multidisciplinary meeting dedicated to endocarditis;
- •- Patient beneficiary of a social security scheme;
- •- Free, informed and written consent signed by the participant and the investigator.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
Exclusion Criteria
- •- pregnant or breastfeeding women;
- •- women of childbearing potential not using effective contraception;
- •- patients referred to in articles L.1121-5 to L.1121-8 (persons deprived of liberty by judicial or administrative decision, minors, adults subject to a legal protection measure or unable to express their consent);
- •- subject in a period of relative exclusion due to another protocol;
- •- known contraindication to PET/CT with injection of radiotracers (hypersensitivity to radiopharmaceuticals and/or excipients).
Investigators
Similar Trials
Active, not recruiting
Phase 1
Contribution of PET/CT with Gallium 68 citrate (68Ga-PET/CT) for the diagnosis of prosthetic valve infective endocarditis - CiGal-EI-TEPProsthetic valve infective endocarditisCTIS2024-514331-24-00Centre Hospitalier Universitaire De Bordeaux40
Completed
Phase 2
Contribution of PET/CT With Gallium 68 Citrate (68Ga-PET/CT) for the Diagnosis of Prosthetic Valve Infective EndocarditisInfective EndocarditisNCT05446376University Hospital, Bordeaux19
Not yet recruiting
Not Applicable
â??Use of Gallium-68PET-CT in the Diagnosis and Follow-up of patients with Prostate Cancerâ??CTRI/2018/07/014933International Atomic Energy Agency
Active, not recruiting
Early Phase 1
An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine TumorsGanglioneuroblastomaGanglioneuromaNeuroblastomaNCT04040088Mayo Clinic20
Completed
Phase 2
Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA)Giant Cell ArteritisNCT03812302University of Alberta9